Страна: Соединенные Штаты
Язык: английский
Источник: NLM (National Library of Medicine)
OXYCODONE HYDROCHLORIDE (UNII: C1ENJ2TE6C) (OXYCODONE - UNII:CD35PMG570), ACETAMINOPHEN (UNII: 362O9ITL9D) (ACETAMINOPHEN - UNII:362O9ITL9D)
Alvogen, Inc.
OXYCODONE HYDROCHLORIDE
OXYCODONE HYDROCHLORIDE 7.5 mg
ORAL
PRESCRIPTION DRUG
Oxycodone and acetaminophen tablets is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Limitations of Use: Because of the risks of addiction, abuse, and misuse, with opioids, , which can occur at any dosage or duration [see WARNINGS ] , reserve oxycodone and acetaminophen tablets for use in patients for whom alternative treatment options (e.g., non-opioid analgesics): • Have not been tolerated, or are not expected to be tolerated, • Have not provided adequate analgesia, or are not expected to provide adequate analgesia Oxycodone and acetaminophen tablets should not be used for an extended period of time unless the pain remains severe enough to require an opioid analgesic and for which alternative treatment options continue to be inadequate. Oxycodone and acetaminophen tablets is contraindicated in patients with: - Significant respiratory depression [see WARNINGS ] - Acute or severe bronchial asthma in an unmonitor
Oxycodone and Acetaminophen Tablets, USP are supplied as follows: Oxycodone and Acetaminophen Tablets, USP 5 mg/325 mg Blue, round tablet, debossed with "ALV" over "196", separated by a bisect, on one side, and plain on the other side. Bottles of 100 NDC 47781-196-01 Bottles of 250 NDC 47781-196-63 Bottles of 500 NDC 47781-196-05 Oxycodone and Acetaminophen Tablets, USP 7.5 mg/325 mg Orange to yellow, round tablet, debossed with “229” on one side and “”on the other side. Bottles of 100 NDC 47781-229-01 Bottles of 250 NDC 47781-229-63 Bottles of 500 NDC 47781-229-05 Oxycodone and Acetaminophen Tablets, USP 10 mg/325 mg Yellow, round tablet, debossed with “230” on one side and “” on the other side. Bottles of 100 NDC 47781-230-01 Bottles of 250 NDC 47781-230-63 Bottles of 500 NDC 47781-230-05 Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Protect from moisture. Dispense in a tight, light-resistant container as defined in the USP. Store Oxycodone and Acetaminophen Tablets, USP securely and dispose of properly [see PRECAUTIONS; Information for Patients and/or Caregivers ] .
Abbreviated New Drug Application
OXYCODONE AND ACETAMINOPHEN- OXYCODONE AND ACETAMINOPHEN TABLET Alvogen, Inc. Reference Label Set Id: 94b95304-8d3b-496a-8d2c-22ae89688427 ---------- Medication Guide Oxycodone (ox" i koe' done) and Acetaminophen (a seet" a min' oh fen) Tablets, CII Oxycodone and Acetaminophen Tablets are: • A strong prescription pain medicine that contains an opioid (narcotic) that is used to manage pain, severe enough to require an opioid analgesic and for which alternative treatments are inadequate and when other pain treatments such as non-opioid pain medicines do not treat your pain well enough or you cannot tolerate them. • An opioid pain medicine that can put you at risk for overdose and death. Even if you take your dose correctly as prescribed you are at risk for opioid addiction, abuse, and misuse that can lead to death. Important information about Oxycodone and Acetaminophen Tablets : • Get emergency help or call 911 right away if you take too much oxycodone and acetaminophen tablets (overdose). When you first start taking oxycodone and acetaminophen tablets, when your dose is changed, or if you take too much (overdose), serious or life-threatening breathing problems that can lead to death may occur. Talk to your healthcare provider about naloxone, a medicine for the emergency treatment of an opioid overdose. • Taking oxycodone and acetaminophen tablets with other opioid medicines, benzodiazepines, alcohol, or other central nervous system depressants (including street drugs) can cause severe drowsiness, decreased awareness, breathing problems, coma, and death. • Never give anyone else your oxycodone and acetaminophen tablets. They could die from taking it. Selling or giving away oxycodone and acetaminophen tablets is against the law. • Store oxycodone and acetaminophen tablets securely, out of sight and reach of children, and in a location not accessible by others, including visitors to the home. Do not take Oxycodone and Acetaminophen Tablets if you have : • Severe asthma, trouble breathing, or other lung Прочитать полный документ
OXYCODONE AND ACETAMINOPHEN- OXYCODONE AND ACETAMINOPHEN TABLET ALVOGEN, INC. REFERENCE LABEL SET ID: 94B95304-8D3B-496A-8D2C-22AE89688427 ---------- OXYCODONE AND ACETAMINOPHEN TABLETS, USP CII RX ONLY WARNING: SERIOUS AND LIFE-THREATENING RISKS FROM USE OF OXYCODONE AND ACETAMINOPHEN TABLETS ADDICTION, ABUSE, AND MISUSE Because the use of oxycodone and acetaminophen tablets exposes patients and other users to the risks of opioid addiction, abuse, and misuse, which can lead to overdose and death, assess each patient’s risk prior to prescribing and reassess all patients regularly for the development of these behaviors and conditions _[SEE_ _WARNINGS]_. LIFE-THREATENING RESPIRATORY DEPRESSION Serious, life-threatening, or fatal respiratory depression may occur with use of oxycodone and acetaminophen tablets, especially during initiation or following a dose increase. To reduce the risk of respiratory depression, proper dosing and titration of oxycodone and acetaminophen tablets are essential _[SEE WARNINGS]_. ACCIDENTAL INGESTION Accidental ingestion of even one dose of oxycodone and acetaminophen tablets, especially by children, can result in a fatal overdose of oxycodone and acetaminophen _[SEE WARNINGS]_. RISKS FROM CONCOMITANT USE WITH BENZODIAZEPINES OR OTHER CNS DEPRESSANTS Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. Reserve concomitant prescribing of oxycodone and acetaminophen tablets and benzodiazepines or other CNS depressants for use in patients for whom alternative treatment options are inadequate _[SEE WARNINGS,_ _PRECAUTIONS, DRUG INTERACTIONS]_. NEONATAL OPIOID WITHDRAWAL SYNDROME (NOWS) If opioid use is required for an extended period of time in a pregnant woman, advise the patient of the risk of NOWS, which may be life-threatening if not recognized and treated. Ensure that management by neonatology experts will be available at delivery _[SEE WARNINGS] Прочитать полный документ